Minnesota will receive more than $50 million for opioid addiction treatment and prevention under a massive legal settlement reached between multiple states and the family behind Purdue Pharma, maker of OxyContin.
Attorney General Keith Ellison said Thursday that the Sackler family and its company will also be required to turn over a trove of more than 30 million documents said to detail Purdue Pharma's role in the country's long-running opioid crisis — which state officials say has killed nearly 5,000 Minnesotans since 2000.
If a judge approves Thursday's announced settlement, the Sackler family will pay more than $4.3 billion for opioid treatment efforts nationwide, one of the largest law enforcement settlements in history.
"The fact is you can always second-guess a settlement, and I'm sure people will — that's what they do," Ellison said. "But the bottom line is we are proud to stand with Minnesotans to get the resources they need as soon as they can and to tell the truth about what these folks did."
In a statement Thursday, Connecticut-based Purdue Pharma said it would "continue to work to build even greater consensus" for its reorganization plan, "which would transfer billions of dollars of value into trusts for the benefit of the American people and direct critically-needed medicines and resources to communities and individuals nationwide who have been affected by the opioid crisis."
Minnesota first filed a consumer fraud lawsuit in Hennepin County in 2018 against Purdue Pharma, litigation modeled after successful efforts to sue tobacco companies. The state accused the company of deliberately minimizing its product's addictiveness and said that Purdue failed to sufficiently disclose the risks of long-term opioid use.
Minnesota alleged that Purdue misled health care providers about the benefits of opioids and made false statements in advertising, among other claims.
Ellison later added the Sackler family as defendants, alleging that the family personally carried out Purdue's deceptive sales and marketing practices. He claimed that the Sacklers "were involved with Purdue sales force decisions on a granular level."